Table 3.

The comparison of spherical equivalent, anterior chamber length, and axial length among the study groups in the measured intervals

	Variable	Placebo	0.1% Atropine	0.01% Atropine	P
Far visual acuity	Baseline	0.063±0.046	0.057±0.036	0.070±0.051	0.454*
	After 1 month	0.062±0.047	0.050±0.040	0.068±0.049	0.226*
	After 3 months	0.061±0.044	0.042±0.031	0.57±0.47	0.107*
	After 6 months	0.061±0.045	0.033±0.028	0.048±0.044	0.009*
	After 12 months	0.063±0.045	0.064±0.039	0.067±0.042	0.880*
	Month 1 vs. baseline	0.00±0.01	-0.01±0.02	0.00±0.01	0.065†
	Month 3 vs. baseline	0.00±0.01	-0.02±0.02	-0.01±0.02	0.003†
	Month 6 vs. baseline	0.00±0.01	-0.02±0.02	-0.02±0.02	<0.001†
	Month 12 vs. baseline	0.00±0.01	0.01±0.02	0.00±0.02	0.039†
Near visual acuity	Baseline	0.003±0.011	0.005±0.014	0.001±0.007	0.340*
	After 1 month	0.003±0.011	0.017±0.027	0.004±0.013	0.001*
	After 3 months	0.002±0.09	0.022±0.029	0.007±0.015	0.001*
	After 6 months	0.003±0.009	0.030±0.025	0.008±0.014	0.001*
	After 12 months	0.002±0.009	0.010±0.016	0.012±0.00	0.017*
	Month 1 vs. baseline	0.00±0.00	0.01±0.02	0.00±0.01	0.001†
	Month 3 vs. baseline	0.00±0.01	0.02±0.02	0.01±0.01	<0.001†
	Month 6 vs. baseline	0.00±0.01	0.02±0.02	0.01±0.00	<0.001†
	Month 12 vs. baseline	0.00±0.01	0.01±0.01	0.00±0.01	0.017†

*The results of One-Way ANOVA, ^†The result of repeated measures ANOVA test